Published on January 26, 2025, 03:02 PM UTC
Tags: employment job search career development resume writing interview preparation
BioMarin Pharmaceutical (NASDAQ: BMRN) reported strong Q4 results, beating analyst estimates for both revenue and EPS. The company's full-year revenue guidance came in above expectations, and its adjusted EPS guidance for the upcoming year is also above estimates. BioMarin's key takeaways for Q4 include revenue growth of 15.6% year-over-year, adjusted EPS of $0.92 vs. estimates of $0.74, revenue guidance of $3.15 billion, and adjusted EPS guidance of $4.30.
Published on: February 19, 2025, 10:11 PM UTC
Elon Musk's DOGE team gains access to sensitive Social Security data, sparking concerns about privacy and program stability. The move follows a pattern of Musk allies seeking sensitive information from federal agencies. The Social Security Administration has replaced its acting head amid the controversy.
Published on: February 18, 2025, 08:02 PM UTC
Capstone Green Energy Corporation reports a fiscal third-quarter loss of $2.7 million, after reporting a profit in the same period a year earlier.
Published on: February 14, 2025, 12:06 PM UTC
Sony raises operating profit forecast, driven by strong gaming and music businesses.
Published on: February 13, 2025, 07:04 AM UTC
Super Micro Computer Inc. sets aggressive revenue target of $40 billion by 2026, despite near-term challenges and ongoing regulatory scrutiny.
Published on: February 12, 2025, 12:04 PM UTC